证券记录 · 已归档季度
VRNA
Verona Pharma plc · Healthcare · Biotechnology
15被追踪持有人
+1Δ持有人
9.80M持有股份
$926.97M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +7.1% ·
股份流向 +10.0% ·
净新建仓位 +6.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2025 | 17 | -1 | 15.38M | $1.64B | +3 | −4 |
| Q2 2025 | 15 | +1 | 9.80M | $926.97M | +1 | — |
| Q1 2025 | 12 | +1 | 8.25M | $524.09M | +1 | — |
| Q4 2024 | 11 | +3 | 8.58M | $398.41M | +3 | — |
| Q3 2024 | 8 | -1 | 5.38M | $154.86M | +1 | −2 |
| Q2 2024 | 9 | — | 3.45M | $49.92M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 1.79M | -4.1% | $169.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 1.42M | +130.5% | $133.85M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.40M | +306.3% | $132.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.40M | +306.3% | $132.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Duquesne Family Office ✦ | 1.00M | 0.0% | $94.78M | 2.4% | Held | 4 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 816.72K | -49.9% | $77.24M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 377.17K | +16.6% | $35.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 350.54K | +342.5% | $33.15M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 312.39K | — | $29.55M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 312.39K | — | $29.55M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 147.40K | +48.9% | $13.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Point72 Asset Management ✦ | 118.58K | +25.7% | $11.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 68.43K | +18.6% | $6.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 26.35K | +113.7% | $2.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (被动) | 6.32K | 新增 | $597,746 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| State Street Global Advisors | $597,746 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据